AI Medical Imaging - Comprehensive Study by Type (X-rays, Computed Tomography Scan, Magnetic Resonance Imaging, Others), Application (Cardiovascular, Neurology, Oncology, Pathology, Others), End-User (Hospitals, R&D Centres, Laboratories and Diagnostic Centres) Players and Region - Global Market Outlook to 2027

AI Medical Imaging - Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
AI Medical Imaging - Market Scope
Medical imaging is a diagnostic procedure that involves the creation of visual aids and image representations of the human body and involves the monitoring of the performance and functioning of the organs of the human body. Technological advancements change the way of diagnostics and the entire procedure, which is carried out with the integration of artificial intelligence in healthcare and medical imaging this factor driving the market of AI medical imaging across the globe. The rising incidence of chronic diseases such as cardiovascular, and neurological disorders combined with realigned healthcare system lea to an increased emphasis on early diagnosis.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledSiemens Healthineers AG (Germany), Fujifilm Holdings Corporation (Japan), GE Healthcare (United States), Imagia Cybernetics Inc (Canada), Nuance Communications Inc. (United States), Koninklijke Philips N.V. (Netherland), Arterys Inc. (United States), Samsung Electronics Co. Ltd. (South Korea), Zebra Medical Vision Inc. (Israel) and Resonance Health Ltd. (Australia)
CAGR%


Global Ai medical imaging market is fragmented. So the players are focusing transformation of the surgery with the high-ultra resolution, real-time, advanced imaging tools to address high unmet medical needs. These will enhance their market presence. The companies are also planning strategic activities like partnerships, mergers, and acquisitions and it maintains their growth at a competitive edge.

Siemens Healthineers AG (Germany), Fujifilm Holdings Corporation (Japan), GE Healthcare (United States), Imagia Cybernetics Inc (Canada), Nuance Communications Inc. (United States), Koninklijke Philips N.V. (Netherland), Arterys Inc. (United States), Samsung Electronics Co. Ltd. (South Korea), Zebra Medical Vision Inc. (Israel) and Resonance Health Ltd. (Australia) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Bay Labs Inc. (United States) and IBM Corporation (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global AI Medical Imaging - market by Type , by Application (Cardiovascular, Neurology, Oncology, Pathology and Others) and Region with country level break-up.

On the basis of geography, the market of AI Medical Imaging - has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2021.

Market Leaders and their expansionary development strategies
On 9th November 2021, Nanox announced the acquisition of the Zebra medical vision, now which is operative as Nanox.AI, in an all-stock deal valued at around USD 110 at closing. Concurrently, Nanox has done two further acquisitions namely USARAD and MDWEB, a centralized marketplace connecting radiologists with imaging facilities.
On 2nd May 2022, Perimeter Medical Imaging AI, Inc is a medical technology company, driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs.


AI Medical Imaging - Market Dynamics:
AttributesDetails
Trends Influencing Market
  • Continuous Developments in the Field of Imaging Technology
Key Restraints
  • Frequent Product Recall Hindering the AI Medical Imaging Market
Challenges
  • Lack of Standardised Evaluation of Scientific Integrity and Clinical Relevance
  • Concerns with Data of Analytics Algorithms
Market Opportunities
  • The emergence of Advanced AI Tools and Technology
  • Adoption of AI in Medical Radiology Creating Opportunity for AI in Medical Imaging Industry


Key Target Audience
AI Medical Imaging services, Regulatory Bodies, Potential Investors, Research and Development Institutes and Others

Report Objectives / Segmentation Covered

By Type
  • X-rays
  • Computed Tomography Scan
  • Magnetic Resonance Imaging
  • Others
By Application
  • Cardiovascular
  • Neurology
  • Oncology
  • Pathology
  • Others
By End-User
  • Hospitals
  • R&D Centres
  • Laboratories and Diagnostic Centres

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Demand for Oncology Imaging
      • 3.2.2. Growing Awareness for Healthcare Services for the Aging Population
    • 3.3. Market Challenges
      • 3.3.1. Lack of Standardised Evaluation of Scientific Integrity and Clinical Relevance
      • 3.3.2. Concerns with Data of Analytics Algorithms
    • 3.4. Market Trends
      • 3.4.1. Continuous Developments in the Field of Imaging Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global AI Medical Imaging -, by Type, Application, End-User and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global AI Medical Imaging - (Value)
      • 5.2.1. Global AI Medical Imaging - by: Type (Value)
        • 5.2.1.1. X-rays
        • 5.2.1.2. Computed Tomography Scan
        • 5.2.1.3. Magnetic Resonance Imaging
        • 5.2.1.4. Others
      • 5.2.2. Global AI Medical Imaging - by: Application (Value)
        • 5.2.2.1. Cardiovascular
        • 5.2.2.2. Neurology
        • 5.2.2.3. Oncology
        • 5.2.2.4. Pathology
        • 5.2.2.5. Others
      • 5.2.3. Global AI Medical Imaging - by: End-User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. R&D Centres
        • 5.2.3.3. Laboratories and Diagnostic Centres
      • 5.2.4. Global AI Medical Imaging - Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Australia
          • 5.2.4.2.6. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global AI Medical Imaging - (Price)
      • 5.3.1. Global AI Medical Imaging - by: Type (Price)
  • 6. AI Medical Imaging -: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Siemens Healthineers AG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Fujifilm Holdings Corporation (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GE Healthcare (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Imagia Cybernetics Inc (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nuance Communications Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Koninklijke Philips N.V. (Netherland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Arterys Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Samsung Electronics Co. Ltd. (South Korea)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Zebra Medical Vision Inc. (Israel)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Resonance Health Ltd. (Australia)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global AI Medical Imaging - Sale, by Type, Application, End-User and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global AI Medical Imaging - (Value)
      • 7.2.1. Global AI Medical Imaging - by: Type (Value)
        • 7.2.1.1. X-rays
        • 7.2.1.2. Computed Tomography Scan
        • 7.2.1.3. Magnetic Resonance Imaging
        • 7.2.1.4. Others
      • 7.2.2. Global AI Medical Imaging - by: Application (Value)
        • 7.2.2.1. Cardiovascular
        • 7.2.2.2. Neurology
        • 7.2.2.3. Oncology
        • 7.2.2.4. Pathology
        • 7.2.2.5. Others
      • 7.2.3. Global AI Medical Imaging - by: End-User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. R&D Centres
        • 7.2.3.3. Laboratories and Diagnostic Centres
      • 7.2.4. Global AI Medical Imaging - Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Australia
          • 7.2.4.2.6. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global AI Medical Imaging - (Price)
      • 7.3.1. Global AI Medical Imaging - by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. AI Medical Imaging -: by Type(USD Million)
  • Table 2. AI Medical Imaging - X-rays , by Region USD Million (2016-2021)
  • Table 3. AI Medical Imaging - Computed Tomography Scan , by Region USD Million (2016-2021)
  • Table 4. AI Medical Imaging - Magnetic Resonance Imaging , by Region USD Million (2016-2021)
  • Table 5. AI Medical Imaging - Others , by Region USD Million (2016-2021)
  • Table 6. AI Medical Imaging -: by Application(USD Million)
  • Table 7. AI Medical Imaging - Cardiovascular , by Region USD Million (2016-2021)
  • Table 8. AI Medical Imaging - Neurology , by Region USD Million (2016-2021)
  • Table 9. AI Medical Imaging - Oncology , by Region USD Million (2016-2021)
  • Table 10. AI Medical Imaging - Pathology , by Region USD Million (2016-2021)
  • Table 11. AI Medical Imaging - Others , by Region USD Million (2016-2021)
  • Table 12. AI Medical Imaging -: by End-User(USD Million)
  • Table 13. AI Medical Imaging - Hospitals , by Region USD Million (2016-2021)
  • Table 14. AI Medical Imaging - R&D Centres , by Region USD Million (2016-2021)
  • Table 15. AI Medical Imaging - Laboratories and Diagnostic Centres , by Region USD Million (2016-2021)
  • Table 16. South America AI Medical Imaging -, by Country USD Million (2016-2021)
  • Table 17. South America AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 18. South America AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 19. South America AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 20. Brazil AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 21. Brazil AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 22. Brazil AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 23. Argentina AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 24. Argentina AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 25. Argentina AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 26. Rest of South America AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 27. Rest of South America AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 28. Rest of South America AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 29. Asia Pacific AI Medical Imaging -, by Country USD Million (2016-2021)
  • Table 30. Asia Pacific AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 31. Asia Pacific AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 32. Asia Pacific AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 33. China AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 34. China AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 35. China AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 36. Japan AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 37. Japan AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 38. Japan AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 39. India AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 40. India AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 41. India AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 42. South Korea AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 43. South Korea AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 44. South Korea AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 45. Australia AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 46. Australia AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 47. Australia AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 48. Rest of Asia-Pacific AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 50. Rest of Asia-Pacific AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 51. Europe AI Medical Imaging -, by Country USD Million (2016-2021)
  • Table 52. Europe AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 53. Europe AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 54. Europe AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 55. Germany AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 56. Germany AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 57. Germany AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 58. France AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 59. France AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 60. France AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 61. Italy AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 62. Italy AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 63. Italy AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 64. United Kingdom AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 65. United Kingdom AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 66. United Kingdom AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 67. Netherlands AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 68. Netherlands AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 69. Netherlands AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 70. Rest of Europe AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 71. Rest of Europe AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 72. Rest of Europe AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 73. MEA AI Medical Imaging -, by Country USD Million (2016-2021)
  • Table 74. MEA AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 75. MEA AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 76. MEA AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 77. Middle East AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 78. Middle East AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 79. Middle East AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 80. Africa AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 81. Africa AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 82. Africa AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 83. North America AI Medical Imaging -, by Country USD Million (2016-2021)
  • Table 84. North America AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 85. North America AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 86. North America AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 87. United States AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 88. United States AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 89. United States AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 90. Canada AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 91. Canada AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 92. Canada AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 93. Mexico AI Medical Imaging -, by Type USD Million (2016-2021)
  • Table 94. Mexico AI Medical Imaging -, by Application USD Million (2016-2021)
  • Table 95. Mexico AI Medical Imaging -, by End-User USD Million (2016-2021)
  • Table 96. AI Medical Imaging -: by Type(USD/Units)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. AI Medical Imaging -: by Type(USD Million)
  • Table 108. AI Medical Imaging - X-rays , by Region USD Million (2022-2027)
  • Table 109. AI Medical Imaging - Computed Tomography Scan , by Region USD Million (2022-2027)
  • Table 110. AI Medical Imaging - Magnetic Resonance Imaging , by Region USD Million (2022-2027)
  • Table 111. AI Medical Imaging - Others , by Region USD Million (2022-2027)
  • Table 112. AI Medical Imaging -: by Application(USD Million)
  • Table 113. AI Medical Imaging - Cardiovascular , by Region USD Million (2022-2027)
  • Table 114. AI Medical Imaging - Neurology , by Region USD Million (2022-2027)
  • Table 115. AI Medical Imaging - Oncology , by Region USD Million (2022-2027)
  • Table 116. AI Medical Imaging - Pathology , by Region USD Million (2022-2027)
  • Table 117. AI Medical Imaging - Others , by Region USD Million (2022-2027)
  • Table 118. AI Medical Imaging -: by End-User(USD Million)
  • Table 119. AI Medical Imaging - Hospitals , by Region USD Million (2022-2027)
  • Table 120. AI Medical Imaging - R&D Centres , by Region USD Million (2022-2027)
  • Table 121. AI Medical Imaging - Laboratories and Diagnostic Centres , by Region USD Million (2022-2027)
  • Table 122. South America AI Medical Imaging -, by Country USD Million (2022-2027)
  • Table 123. South America AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 124. South America AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 125. South America AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 126. Brazil AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 127. Brazil AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 128. Brazil AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 129. Argentina AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 130. Argentina AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 131. Argentina AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 132. Rest of South America AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 133. Rest of South America AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 134. Rest of South America AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 135. Asia Pacific AI Medical Imaging -, by Country USD Million (2022-2027)
  • Table 136. Asia Pacific AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 137. Asia Pacific AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 138. Asia Pacific AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 139. China AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 140. China AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 141. China AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 142. Japan AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 143. Japan AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 144. Japan AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 145. India AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 146. India AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 147. India AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 148. South Korea AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 149. South Korea AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 150. South Korea AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 151. Australia AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 152. Australia AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 153. Australia AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 154. Rest of Asia-Pacific AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 155. Rest of Asia-Pacific AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 156. Rest of Asia-Pacific AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 157. Europe AI Medical Imaging -, by Country USD Million (2022-2027)
  • Table 158. Europe AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 159. Europe AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 160. Europe AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 161. Germany AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 162. Germany AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 163. Germany AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 164. France AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 165. France AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 166. France AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 167. Italy AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 168. Italy AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 169. Italy AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 170. United Kingdom AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 171. United Kingdom AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 172. United Kingdom AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 173. Netherlands AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 174. Netherlands AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 175. Netherlands AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 176. Rest of Europe AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 177. Rest of Europe AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 178. Rest of Europe AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 179. MEA AI Medical Imaging -, by Country USD Million (2022-2027)
  • Table 180. MEA AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 181. MEA AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 182. MEA AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 183. Middle East AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 184. Middle East AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 185. Middle East AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 186. Africa AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 187. Africa AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 188. Africa AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 189. North America AI Medical Imaging -, by Country USD Million (2022-2027)
  • Table 190. North America AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 191. North America AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 192. North America AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 193. United States AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 194. United States AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 195. United States AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 196. Canada AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 197. Canada AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 198. Canada AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 199. Mexico AI Medical Imaging -, by Type USD Million (2022-2027)
  • Table 200. Mexico AI Medical Imaging -, by Application USD Million (2022-2027)
  • Table 201. Mexico AI Medical Imaging -, by End-User USD Million (2022-2027)
  • Table 202. AI Medical Imaging -: by Type(USD/Units)
  • Table 203. Research Programs/Design for This Report
  • Table 204. Key Data Information from Secondary Sources
  • Table 205. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global AI Medical Imaging -: by Type USD Million (2016-2021)
  • Figure 5. Global AI Medical Imaging -: by Application USD Million (2016-2021)
  • Figure 6. Global AI Medical Imaging -: by End-User USD Million (2016-2021)
  • Figure 7. South America AI Medical Imaging - Share (%), by Country
  • Figure 8. Asia Pacific AI Medical Imaging - Share (%), by Country
  • Figure 9. Europe AI Medical Imaging - Share (%), by Country
  • Figure 10. MEA AI Medical Imaging - Share (%), by Country
  • Figure 11. North America AI Medical Imaging - Share (%), by Country
  • Figure 12. Global AI Medical Imaging -: by Type USD/Units (2016-2021)
  • Figure 13. Global AI Medical Imaging - share by Players 2021 (%)
  • Figure 14. Global AI Medical Imaging - share by Players (Top 3) 2021(%)
  • Figure 15. Global AI Medical Imaging - share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Siemens Healthineers AG (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Siemens Healthineers AG (Germany) Revenue: by Geography 2021
  • Figure 19. Fujifilm Holdings Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 20. Fujifilm Holdings Corporation (Japan) Revenue: by Geography 2021
  • Figure 21. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 22. GE Healthcare (United States) Revenue: by Geography 2021
  • Figure 23. Imagia Cybernetics Inc (Canada) Revenue, Net Income and Gross profit
  • Figure 24. Imagia Cybernetics Inc (Canada) Revenue: by Geography 2021
  • Figure 25. Nuance Communications Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Nuance Communications Inc. (United States) Revenue: by Geography 2021
  • Figure 27. Koninklijke Philips N.V. (Netherland) Revenue, Net Income and Gross profit
  • Figure 28. Koninklijke Philips N.V. (Netherland) Revenue: by Geography 2021
  • Figure 29. Arterys Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Arterys Inc. (United States) Revenue: by Geography 2021
  • Figure 31. Samsung Electronics Co. Ltd. (South Korea) Revenue, Net Income and Gross profit
  • Figure 32. Samsung Electronics Co. Ltd. (South Korea) Revenue: by Geography 2021
  • Figure 33. Zebra Medical Vision Inc. (Israel) Revenue, Net Income and Gross profit
  • Figure 34. Zebra Medical Vision Inc. (Israel) Revenue: by Geography 2021
  • Figure 35. Resonance Health Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 36. Resonance Health Ltd. (Australia) Revenue: by Geography 2021
  • Figure 37. Global AI Medical Imaging -: by Type USD Million (2022-2027)
  • Figure 38. Global AI Medical Imaging -: by Application USD Million (2022-2027)
  • Figure 39. Global AI Medical Imaging -: by End-User USD Million (2022-2027)
  • Figure 40. South America AI Medical Imaging - Share (%), by Country
  • Figure 41. Asia Pacific AI Medical Imaging - Share (%), by Country
  • Figure 42. Europe AI Medical Imaging - Share (%), by Country
  • Figure 43. MEA AI Medical Imaging - Share (%), by Country
  • Figure 44. North America AI Medical Imaging - Share (%), by Country
  • Figure 45. Global AI Medical Imaging -: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Siemens Healthineers AG (Germany)
  • Fujifilm Holdings Corporation (Japan)
  • GE Healthcare (United States)
  • Imagia Cybernetics Inc (Canada)
  • Nuance Communications Inc. (United States)
  • Koninklijke Philips N.V. (Netherland)
  • Arterys Inc. (United States)
  • Samsung Electronics Co. Ltd. (South Korea)
  • Zebra Medical Vision Inc. (Israel)
  • Resonance Health Ltd. (Australia)
Additional players considered in the study are as follows:
Bay Labs Inc. (United States) , IBM Corporation (United States)
Select User Access Type

Key Highlights of Report


Aug 2022 230 Pages 72 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in AI Medical Imaging - Market are by type [X-rays, Computed Tomography Scan, Magnetic Resonance Imaging and Others], by end use application [Cardiovascular, Neurology, Oncology, Pathology and Others].
The AI Medical Imaging - Market is gaining popularity and expected to see strong valuation by 2027.
  • Rising Demand for Oncology Imaging
  • Growing Awareness for Healthcare Services for the Aging Population

Know More About Global AI Medical Imaging - Market Report?